References:
Bellus
GA, Mcintosh I, Smith EA, Aylsworth AS, Francomano CA. 1995. A recurrent
mutation in the tyrosine kinase domain of fibroblast growth factor
receptor 3 causes hypochondroplasia. Nature Genetics 10(3):357-359.
Brunetti-Pierri
N, Andreucci M, Tuzzi R, Vega G, Gray G, McKeown C, Ballabio A, Andria
G, Meroni G, Parenti G. 2003. X-linked recessive chondrodysplasia
punctata: Spectrum of arylsulfatase E gene mutations and expanded
clinical variability. American Journal of Medical Genetics
117A(2):164-168.
Coen
A. C. Ottenheijm CCWG. 2009. Thin filament length dysregulation
contributes to muscle weakness in nemaline myopathy patients with
nebulin deficiency. Hum Mol Genet 18:2359-2369.
D.
MMV, M. M, P. ABV, V. S, O. RAMR, R. NVR, N. AJA, M. Z, V. EFI, D. LI.
2012. Variable expressivity of osteogenesis imperfecta in a Brazilian
family due to p.G1079S mutation in the COL1A1 gene. Genetics &
Molecular Research 11(3):3246-3255.
De
Jong Pleij EAP, Vos FI, Ribbert LSM, Pistorius LR, Tromp E, Bilardo CM.
2012. Prenasal thickness‐to‐nasal bone length ratio: a strong and simple
second‐ and third‐trimester marker for trisomy 21. Ultrasound Obstet
Gynecol 39(2).
Deutz-Terlouw PP, Losekoot M, Aalfs CM, Hennekam RCM, Bakker E. 1998.
Asn540Thr substitution in the fibroblast growth factor receptor 3
tyrosine kinase domain causing hypochondroplasia. Human Mutation.
Foldynova-Trantirkova S, Wilcox WR, Krejci P. 2012. Sixteen years and
counting: The current understanding of fibroblast growth factor receptor
3 (FGFR3) signaling in skeletal dysplasias. Human Mutation 33(1):29-41.
Gay S, Dupuis D, Faivre L, Masurelpaulet A, Labenne M, Colombani M,
Soichot P, Huet F, Hainque B, Sternberg D. 2010. Severe neonatal
non-dystrophic myotonia secondary to a novel mutation of the
voltage-gated sodium channel (SCN4A) gene. American Journal of Medical
Genetics Part A 146A(3):380-383.
Georgoulis
G, Alexiou G, Prodromou N. 2011. Achondroplasia with synostosis of
multiple sutures. American Journal of Medical Genetics Part A
155(8):1969-1971.
Grannum PA, Hobbins JC. 1983. Prenatal diagnosis of fetal skeletal
dysplasias. Seminars in Perinatology 7(2):125.
Kaneko H, Kitoh H, Matsuura T, Masuda A, Ito M, Mottes M, Rauch F,
Ishiguro N, Ohno K. 2011. Hyperuricemia cosegregating with osteogenesis
imperfecta is associated with a mutation in GPATCH8. Human Genetics
130(5):p.671-683.
Lehtokari
VO, Kiiski K, Sandaradura SA, Laporte J, Ettersson CW. 2014. Mutation
Update: The Spectra of Nebulin Variants and Associated Myopathies. Human
Mutation 35(12).
Liu Y,
Wang L, Yang Y, Liang Y, Wu Q. 2019. Prenatal diagnosis of fetal
skeletal dysplasia using targeted next-generation sequencing: an
analysis of 30 cases. Diagnostic Pathology 14(1):76.
Lord
J, McMullan DJ, Eberhardt RY, Rinck G, Wilson E. 2019. Prenatal exome
sequencing analysis in fetal structural anomalies detected by
ultrasonography (PAGE): a cohort study. Lancet 393(10173):747-757.
Matthews E, Manzur AY, Sud R, Muntoni F, Hanna MG. 2011. Stridor as a
Neonatal Presentation of Skeletal Muscle Sodium Channelopathy. Archives
of Neurology 68(1):127—129.
Miraoui H, Ringe J, Häupl T. 2010. Increased EFG- and PDGFα-receptor
signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction
in Apert craniosynostosis. Human Molecular Genetics 19(9):p.1678-1689.
Pan C,
Tseng Y, Lan T, Chang H. 2017. Craniofacial features of cleidocranial
dysplasia. Journal of Dental Sciences:S1991790217301009.
Pauli RM. 2019. Achondroplasia: a comprehensive clinical review.
Orphanet Journal of Rare Diseases 14(1).
Petrovski S, Aggarwal V, Giordano JL, Stosic M, Wou K, Bier L, Spiegel
E, Brennan K, Stong N, Jobanputra V. 2019. Whole-exome sequencing in the
evaluation of fetal structural anomalies: a prospective cohort study.
Lancet 393(10173):758-767.
Richards
S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M,
Lyon E, Spector E. 2015. Standards and guidelines for the interpretation
of sequence variants: a joint consensus recommendation of the American
College of Medical Genetics and Genomics and the Association for
Molecular Pathology. Genetics in Medicine Official Journal of the
American College of Medical Genetics 17(5):405-423.
Tang J, Zhou C, Shi H, Mo Y, Luo L. 2020. Prenatal diagnosis of skeletal
dysplasias using whole exome sequencing in China. Clinica Chimica Acta
507.
Tarja, Linnankivi, Outi, Mäkitie, Leena, Valanne, Sanna,
Toiviainen-Salo. 2012. Neuroimaging and neurological findings in
patients with hypochondroplasia andFGFR3N540K mutation. American Journal
of Medical Genetics Part A.
W RD,
R SJ, M P, S S. 1985. Diminished type I collagen synthesis and reduced
alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients
with dominantly inherited (type I) osteogenesis imperfecta. Journal of
Clinical Investigation.
Waller
DK, Correa A, Vo TM, Wang Y, Hobbs C, Langlois PH, Pearson K, Romitti
PA, Shaw GM, Hecht JT. 2008. The population-based prevalence of
achondroplasia and thanatophoric dysplasia in selected regions of the
US. American Journal of Medical Genetics Part A 146A(18):2385-2389.
Warman
ML, Cormier-Daire V, Hall C, Krakow D, Lachman R, Lemerrer M, Mortier G,
Mundlos S, Nishimura G, Rimoin DL. 2011. Nosology and classification of
genetic skeletal disorders: 2010 revision. American Journal of Medical
Genetics Part A 155(5):943-968.
Willing
MC, Cohn DH, Byers PH. 1990. Frameshift mutation near the 3’ end of the
COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I)
chain and results in osteogenesis imperfecta type I. Journal of Clinical
Investigation 85(1):282-90.
Wynn
J, King TM, Gambello MJ, Waller DK, Hecht JT. 2007. Mortality in
achondroplasia study: A 42-year follow-up. American Journal of Medical
Genetics Part A 143A(21):2502-2511.
Xue Y,
Sun A, Mekikian PB, Martin J, Wilcox WR. 2014. FGFR3 mutation frequency
in 324 cases from the International Skeletal Dysplasia Registry. Mol
Genet Genomic Med 2(6):497-503.
Yang K, Shen M, Yan Y, Tan Y, Tian Y. 2019. Genetic Analysis in Fetal
Skeletal Dysplasias by Trio Whole-Exome Sequencing. BioMed Research
International 2019(2):1-8.
Zhu JL, Hasle H, Correa A, Schendel D, Friedman JM, Olsen J, Rasmussen
SA. 2013. Survival among people with Down syndrome: a nationwide
population-based study in Denmark. Genet Med 15(1):64-9.